Juno Therapeutics Inc. priced its initial public offering above the expected range late Thursday. Juno said it will offer 11 million shares at $24 apiece. The expected range on the IPO was $21 to $23 a share. Juno is a biotech company that is developing cancer therapies. Shares will begin trading on the Nasdaq on Friday.
Copyright © 2014 MarketWatch, Inc.
Continue Reading Below